Stock Track | Spyre Therapeutics Soars 6.99% in Pre-Market on Multiple Analyst Target Price Hikes

Stock Track04-14

Spyre Therapeutics Inc (SYRE) saw its stock price soar 6.99% in pre-market trading on Tuesday.

The surge follows a series of bullish analyst actions, including target price increases from multiple firms. Jefferies raised its target to $85 from $47, Wells Fargo increased to $90 from $50, Leerink Partners lifted to $106 from $49, Mizuho boosted to $84 from $53, Deutsche Bank raised to $88 from $55, and Wedbush upped to $80 from $65. Additionally, Raymond James initiated coverage with a Strong Buy rating and an $80 target price.

These analyst actions reflect growing optimism about the company's prospects, driving investor interest and buying activity in the pre-market session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156497088?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 21:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156497088","market":"nz","top_or_hot":-1,"title":"Stock Track | Spyre Therapeutics Soars 6.99% in Pre-Market on Multiple Analyst Target Price Hikes","media":"Stock Track","content":"<p>Spyre Therapeutics Inc (SYRE) saw its stock price soar 6.99% in pre-market trading on Tuesday.</p><p>The surge follows a series of bullish analyst actions, including target price increases from multiple firms. Jefferies raised its target to $85 from $47, Wells Fargo increased to $90 from $50, Leerink Partners lifted to $106 from $49, Mizuho boosted to $84 from $53, Deutsche Bank raised to $88 from $55, and Wedbush upped to $80 from $65. Additionally, Raymond James initiated coverage with a Strong Buy rating and an $80 target price.</p><p>These analyst actions reflect growing optimism about the company's prospects, driving investor interest and buying activity in the pre-market session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Spyre Therapeutics Soars 6.99% in Pre-Market on Multiple Analyst Target Price Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Spyre Therapeutics Soars 6.99% in Pre-Market on Multiple Analyst Target Price Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-14 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Spyre Therapeutics Inc (SYRE) saw its stock price soar 6.99% in pre-market trading on Tuesday.</p><p>The surge follows a series of bullish analyst actions, including target price increases from multiple firms. Jefferies raised its target to $85 from $47, Wells Fargo increased to $90 from $50, Leerink Partners lifted to $106 from $49, Mizuho boosted to $84 from $53, Deutsche Bank raised to $88 from $55, and Wedbush upped to $80 from $65. Additionally, Raymond James initiated coverage with a Strong Buy rating and an $80 target price.</p><p>These analyst actions reflect growing optimism about the company's prospects, driving investor interest and buying activity in the pre-market session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYRE","symbol_name":"SPYRE THERAPEUTICS INC","start_time":0,"source_url":"","article_id":"1156497088","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156497088","pubTimestamp":1776173485,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Spyre Therapeutics Inc (SYRE) saw its stock price soar 6.99% in pre-market trading on Tuesday.The surge follows a series of bullish analyst actions, including target price increases from multiple...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SYRE":"SPYRE THERAPEUTICS INC"},"translate_title":"个股追踪|Spyre Therapeutics盘前大涨6.99%多分析师上调目标价","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRE":1},"content_text":"Spyre Therapeutics Inc (SYRE) saw its stock price soar 6.99% in pre-market trading on Tuesday.The surge follows a series of bullish analyst actions, including target price increases from multiple firms. Jefferies raised its target to $85 from $47, Wells Fargo increased to $90 from $50, Leerink Partners lifted to $106 from $49, Mizuho boosted to $84 from $53, Deutsche Bank raised to $88 from $55, and Wedbush upped to $80 from $65. Additionally, Raymond James initiated coverage with a Strong Buy rating and an $80 target price.These analyst actions reflect growing optimism about the company's prospects, driving investor interest and buying activity in the pre-market session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156497088","isCrawlerRequest":true}